The Food and Drug Administration has approved subcutaneously-injected tocilizumab (Actemra)
Anthracycline-Free Neoadjuvant Regimen Safe, Effective for TNBC
For patients with triple-negative breast cancer (TNBC), neoadjuvant carboplatin plus
Surgeon Calls Into Virtual Court Trial During Operation
A Zoom video conference collage captured by The Sacramento Bee